CA2011874A1 - Peptides sdk, procede de preparation et composes therapeutiques les contenants - Google Patents

Peptides sdk, procede de preparation et composes therapeutiques les contenants

Info

Publication number
CA2011874A1
CA2011874A1 CA2011874A CA2011874A CA2011874A1 CA 2011874 A1 CA2011874 A1 CA 2011874A1 CA 2011874 A CA2011874 A CA 2011874A CA 2011874 A CA2011874 A CA 2011874A CA 2011874 A1 CA2011874 A1 CA 2011874A1
Authority
CA
Canada
Prior art keywords
same
compositions containing
therapeutic compositions
preparation process
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2011874A
Other languages
English (en)
Other versions
CA2011874C (fr
Inventor
Maryse Lenfant
Josiane Thierry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Maryse Lenfant
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R .A.S.)
Josiane Thierry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maryse Lenfant, Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R .A.S.), Josiane Thierry filed Critical Maryse Lenfant
Publication of CA2011874A1 publication Critical patent/CA2011874A1/fr
Application granted granted Critical
Publication of CA2011874C publication Critical patent/CA2011874C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
CA002011874A 1989-03-11 1990-03-09 Peptides sdk, procede de preparation et composes therapeutiques les contenants Expired - Fee Related CA2011874C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8905606.3 1989-03-11
GB898905606A GB8905606D0 (en) 1989-03-11 1989-03-11 Peptides

Publications (2)

Publication Number Publication Date
CA2011874A1 true CA2011874A1 (fr) 1990-09-11
CA2011874C CA2011874C (fr) 1998-07-21

Family

ID=10653152

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002011874A Expired - Fee Related CA2011874C (fr) 1989-03-11 1990-03-09 Peptides sdk, procede de preparation et composes therapeutiques les contenants

Country Status (32)

Country Link
US (1) US5112811A (fr)
JP (1) JPH0347197A (fr)
KR (1) KR0133850B1 (fr)
AR (1) AR245139A1 (fr)
AT (1) AT402822B (fr)
AU (1) AU631197B2 (fr)
BE (1) BE1003996A3 (fr)
CA (1) CA2011874C (fr)
CH (1) CH680666A5 (fr)
DE (1) DE4007605B4 (fr)
DK (1) DK173932B1 (fr)
ES (1) ES2023746A6 (fr)
FI (1) FI901196A0 (fr)
FR (2) FR2644164A1 (fr)
GB (2) GB8905606D0 (fr)
GR (1) GR1000344B (fr)
HK (1) HK95392A (fr)
IE (1) IE64762B1 (fr)
IN (1) IN173870B (fr)
IT (1) IT1240933B (fr)
LU (1) LU87696A1 (fr)
MA (1) MA21770A1 (fr)
MY (1) MY106274A (fr)
NL (1) NL194918C (fr)
NO (1) NO901129L (fr)
NZ (1) NZ232815A (fr)
OA (1) OA09197A (fr)
PT (1) PT93380B (fr)
SE (1) SE9000793L (fr)
SG (1) SG91892G (fr)
TN (1) TNSN90027A1 (fr)
ZA (1) ZA901718B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
DE4224509C2 (de) * 1992-07-24 1995-04-20 Ruhenstroth Bauer Gerhard Prof Wirkstoff zur Hemmung der Proliferationsrate von Leberzellen
RU2302870C1 (ru) * 2006-06-22 2007-07-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Средство, обладающее геропротекторной активностью, и способ его получения

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US216088A (en) * 1879-06-03 Improvement in bale-ties
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
FR2565985B1 (fr) * 1984-06-19 1987-09-25 Rhone Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
AU589919B2 (en) * 1984-10-15 1989-10-26 Cetus Corp Human tumor necrosis factor
FR2601678B1 (fr) * 1986-07-18 1989-11-24 Inst Nat Sante Rech Med Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie
FR2622587B1 (fr) * 1987-10-30 1990-12-21 Inst Vaisseaux Sang Peptide lysyl-arginyl-aspartyl-serine et ses applications en tant que medicament, notamment antithrombotique
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤

Also Published As

Publication number Publication date
FI901196A0 (fi) 1990-03-09
FR2644065A1 (fr) 1990-09-14
HK95392A (en) 1992-12-04
DE4007605A1 (de) 1990-09-13
NL9000551A (nl) 1990-10-01
IT9019630A0 (it) 1990-03-09
AU631197B2 (en) 1992-11-19
GB9005069D0 (en) 1990-05-02
NO901129L (no) 1990-09-12
NO901129D0 (no) 1990-03-09
NZ232815A (en) 1992-06-25
IE900850L (en) 1990-09-11
AR245139A1 (es) 1993-12-30
CA2011874C (fr) 1998-07-21
AU5117590A (en) 1990-09-13
IT1240933B (it) 1993-12-27
US5112811A (en) 1992-05-12
GR1000344B (el) 1992-06-25
GR900100164A (en) 1990-07-31
OA09197A (fr) 1992-06-30
IE64762B1 (en) 1995-09-06
FR2644164A1 (fr) 1990-09-14
ATA53290A (de) 1997-01-15
NL194918B (nl) 2003-03-03
BE1003996A3 (fr) 1992-09-08
KR0133850B1 (ko) 1998-04-21
ZA901718B (en) 1990-12-28
SE9000793D0 (sv) 1990-03-06
CH680666A5 (en) 1992-10-15
FR2644065B1 (fr) 1994-10-07
PT93380A (pt) 1990-11-07
DK62690D0 (da) 1990-03-09
SG91892G (en) 1992-12-04
LU87696A1 (fr) 1990-07-24
GB2228937B (en) 1992-07-08
DE4007605B4 (de) 2006-03-23
FR2644164B1 (fr) 1995-03-17
AT402822B (de) 1997-09-25
DK62690A (da) 1990-09-12
SE9000793L (sv) 1990-09-12
MA21770A1 (fr) 1990-10-01
GB8905606D0 (en) 1989-04-26
KR900014426A (ko) 1990-10-23
MY106274A (en) 1995-04-29
PT93380B (pt) 1997-01-31
IT9019630A1 (it) 1991-09-09
JPH0347197A (ja) 1991-02-28
IN173870B (fr) 1994-07-30
ES2023746A6 (es) 1992-02-01
TNSN90027A1 (fr) 1991-03-05
GB2228937A (en) 1990-09-12
DK173932B1 (da) 2002-02-25
NL194918C (nl) 2003-07-04

Similar Documents

Publication Publication Date Title
CA2136751A1 (fr) Sels de peptides avec polyesters a groupe terminal carbonyle
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
CA2150251A1 (fr) Lyospheres contenant de la gonadotropine
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
CA2152615A1 (fr) Compositions pharmaceutiques a base d'atovaquone
CA2041260A1 (fr) Agents de contraste ultrasonore, leur procede de preparation et leur utilisation en tant qu'agents de diagnostic et de traitement
HK1054500A1 (en) Process for the preparation of aerosol compositions.
CA2081150A1 (fr) Utilisation de preparations contenant des anticorps pour l'immunosuppression
CA2331936A1 (fr) Proteines a mutation d'epitopes; procede de fabrication
CA2116764A1 (fr) Compositions de polypeptides du virus de l'hepatite c immunoreactives
CA2110693A1 (fr) Derive d'acide amine anticonvulsif
CA2278201A1 (fr) Nouvelles modifications du 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene et procedes de preparation connexes
IL106600A (en) Peptides, pharmaceutical compositions containing the same and processes for the preparation thereof
GR82243B (fr)
CA2114136A1 (fr) Complexes de gallium (iii), procede de production et compositions pharmaceutiques en contenant
GR3006718T3 (fr)
EP0334244A3 (fr) Peptides antagonistes de Bradykinine
CA2105534A1 (fr) Ligands du tnf
CA2106176A1 (fr) Lipides neutres a partir du noyau de lacryma-jobi
CA2094347A1 (fr) Methode de production d'une preparation de facteur viii
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
WO1999014241A3 (fr) Traitement d'affections liees aux fonctions immunitaires et compositions correspondantes
CA2020663A1 (fr) Analogues de substitution de magainin peptides
IL95618A0 (en) Recombinant aprotinin variants,their preparation and medicaments containing them
CA2011874A1 (fr) Peptides sdk, procede de preparation et composes therapeutiques les contenants

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed